Status:
NOT_YET_RECRUITING
Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction
Lead Sponsor:
Queen Savang Vadhana Memorial Hospital, Thailand
Conditions:
Small Bowel Adhesion
Small Bowel Obstruction
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Adhesive small bowel obstruction (ASBO) is a condition that is commonly found in patients with history of abdominal surgery. The management for such condition can be controversial. In terms of conserv...
Detailed Description
This study is a randomized, controlled and double-blinded study, where participants who were diagnosed with ASBO will be randomly allocated into two groups: (i) A contrast group (CG): Patients will b...
Eligibility Criteria
Inclusion
- Patients who are presented with clinical manifestation of small bowel obstruction due to adhesion and require radiological investigations
- Patients who has history of abdominal surgery over 30 days
Exclusion
- Patients with clinical signs and symptoms of bowel strangulation, ischemia, perforation or peritonitis
- Patients with clinical signs and symptoms of bowel obstruction from non-adhesive causes, including malignancy, herniation, inflammatory bowel disease, Crohn's disease, and others.
- Patients who has history of allergy to water soluble contrast agent
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT06140173
Start Date
June 1 2024
End Date
July 1 2025
Last Update
April 4 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.